Global Recombinant Human Erythropoietin for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 113

Published Date: 01 Nov 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin for Injection market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Recombinant Human Erythropoietin for Injection is a crucial biopharmaceutical product used in the treatment of anemia, with a substantial and continually growing market size. The ongoing aging of the population and the rise in chronic disease patients have maintained a steady demand for erythropoietin. Furthermore, the continuous advancement in biopharmaceutical technology is expected to enhance product efficacy and convenience, expanding potential market applications, including the treatment of kidney disease and cancer patients, offering more opportunities for future development.

The Global Info Research report includes an overview of the development of the Recombinant Human Erythropoietin for Injection industry chain, the market status of Anemia (Epoetin-alfa, Epoetin-beta), Kidney Disorders (Epoetin-alfa, Epoetin-beta), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Human Erythropoietin for Injection.

Regionally, the report analyzes the Recombinant Human Erythropoietin for Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Human Erythropoietin for Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Recombinant Human Erythropoietin for Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Human Erythropoietin for Injection industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Epoetin-alfa, Epoetin-beta).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Human Erythropoietin for Injection market.

Regional Analysis: The report involves examining the Recombinant Human Erythropoietin for Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Human Erythropoietin for Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Recombinant Human Erythropoietin for Injection:
Company Analysis: Report covers individual Recombinant Human Erythropoietin for Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Human Erythropoietin for Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Anemia, Kidney Disorders).

Technology Analysis: Report covers specific technologies relevant to Recombinant Human Erythropoietin for Injection. It assesses the current state, advancements, and potential future developments in Recombinant Human Erythropoietin for Injection areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Human Erythropoietin for Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Recombinant Human Erythropoietin for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Epoetin-alfa
    Epoetin-beta
    Darbepoetin-alfa
    Others

Market segment by Application
    Anemia
    Kidney Disorders
    Others

Major players covered
    Amgen
    Johnson & Johnson
    Roche
    Kyowa Kirin
    LG Chem
    Daewoong Pharmaceutical
    Wockhardt
    CJ Healthcare
    3SBio
    Kexing Biopharm
    Harbin Pharmaceutical Group
    Beijing Four Rings Bio-Pharmaceutical

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Erythropoietin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Erythropoietin for Injection, with price, sales, revenue and global market share of Recombinant Human Erythropoietin for Injection from 2018 to 2023.
Chapter 3, the Recombinant Human Erythropoietin for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Erythropoietin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Erythropoietin for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Erythropoietin for Injection.
Chapter 14 and 15, to describe Recombinant Human Erythropoietin for Injection sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Recombinant Human Erythropoietin for Injection
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Recombinant Human Erythropoietin for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Epoetin-alfa
        1.3.3 Epoetin-beta
        1.3.4 Darbepoetin-alfa
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Recombinant Human Erythropoietin for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Anemia
        1.4.3 Kidney Disorders
        1.4.4 Others
    1.5 Global Recombinant Human Erythropoietin for Injection Market Size & Forecast
        1.5.1 Global Recombinant Human Erythropoietin for Injection Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Recombinant Human Erythropoietin for Injection Sales Quantity (2018-2029)
        1.5.3 Global Recombinant Human Erythropoietin for Injection Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Recombinant Human Erythropoietin for Injection Product and Services
        2.1.4 Amgen Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Recent Developments/Updates
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Recombinant Human Erythropoietin for Injection Product and Services
        2.2.4 Johnson & Johnson Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Johnson & Johnson Recent Developments/Updates
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Recombinant Human Erythropoietin for Injection Product and Services
        2.3.4 Roche Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Roche Recent Developments/Updates
    2.4 Kyowa Kirin
        2.4.1 Kyowa Kirin Details
        2.4.2 Kyowa Kirin Major Business
        2.4.3 Kyowa Kirin Recombinant Human Erythropoietin for Injection Product and Services
        2.4.4 Kyowa Kirin Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Kyowa Kirin Recent Developments/Updates
    2.5 LG Chem
        2.5.1 LG Chem Details
        2.5.2 LG Chem Major Business
        2.5.3 LG Chem Recombinant Human Erythropoietin for Injection Product and Services
        2.5.4 LG Chem Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 LG Chem Recent Developments/Updates
    2.6 Daewoong Pharmaceutical
        2.6.1 Daewoong Pharmaceutical Details
        2.6.2 Daewoong Pharmaceutical Major Business
        2.6.3 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
        2.6.4 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Daewoong Pharmaceutical Recent Developments/Updates
    2.7 Wockhardt
        2.7.1 Wockhardt Details
        2.7.2 Wockhardt Major Business
        2.7.3 Wockhardt Recombinant Human Erythropoietin for Injection Product and Services
        2.7.4 Wockhardt Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Wockhardt Recent Developments/Updates
    2.8 CJ Healthcare
        2.8.1 CJ Healthcare Details
        2.8.2 CJ Healthcare Major Business
        2.8.3 CJ Healthcare Recombinant Human Erythropoietin for Injection Product and Services
        2.8.4 CJ Healthcare Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 CJ Healthcare Recent Developments/Updates
    2.9 3SBio
        2.9.1 3SBio Details
        2.9.2 3SBio Major Business
        2.9.3 3SBio Recombinant Human Erythropoietin for Injection Product and Services
        2.9.4 3SBio Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 3SBio Recent Developments/Updates
    2.10 Kexing Biopharm
        2.10.1 Kexing Biopharm Details
        2.10.2 Kexing Biopharm Major Business
        2.10.3 Kexing Biopharm Recombinant Human Erythropoietin for Injection Product and Services
        2.10.4 Kexing Biopharm Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Kexing Biopharm Recent Developments/Updates
    2.11 Harbin Pharmaceutical Group
        2.11.1 Harbin Pharmaceutical Group Details
        2.11.2 Harbin Pharmaceutical Group Major Business
        2.11.3 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Product and Services
        2.11.4 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
    2.12 Beijing Four Rings Bio-Pharmaceutical
        2.12.1 Beijing Four Rings Bio-Pharmaceutical Details
        2.12.2 Beijing Four Rings Bio-Pharmaceutical Major Business
        2.12.3 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
        2.12.4 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Beijing Four Rings Bio-Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Recombinant Human Erythropoietin for Injection by Manufacturer
    3.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Recombinant Human Erythropoietin for Injection Revenue by Manufacturer (2018-2023)
    3.3 Global Recombinant Human Erythropoietin for Injection Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Recombinant Human Erythropoietin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Recombinant Human Erythropoietin for Injection Manufacturer Market Share in 2022
        3.4.2 Top 6 Recombinant Human Erythropoietin for Injection Manufacturer Market Share in 2022
    3.5 Recombinant Human Erythropoietin for Injection Market: Overall Company Footprint Analysis
        3.5.1 Recombinant Human Erythropoietin for Injection Market: Region Footprint
        3.5.2 Recombinant Human Erythropoietin for Injection Market: Company Product Type Footprint
        3.5.3 Recombinant Human Erythropoietin for Injection Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Recombinant Human Erythropoietin for Injection Market Size by Region
        4.1.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2029)
        4.1.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2029)
        4.1.3 Global Recombinant Human Erythropoietin for Injection Average Price by Region (2018-2029)
    4.2 North America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
    4.3 Europe Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
    4.4 Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
    4.5 South America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
    4.6 Middle East and Africa Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    5.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Type (2018-2029)
    5.3 Global Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    6.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Application (2018-2029)
    6.3 Global Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2029)

7 North America
    7.1 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    7.2 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    7.3 North America Recombinant Human Erythropoietin for Injection Market Size by Country
        7.3.1 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
        7.3.2 North America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    8.2 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    8.3 Europe Recombinant Human Erythropoietin for Injection Market Size by Country
        8.3.1 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
        8.3.2 Europe Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Recombinant Human Erythropoietin for Injection Market Size by Region
        9.3.1 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    10.2 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    10.3 South America Recombinant Human Erythropoietin for Injection Market Size by Country
        10.3.1 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
        10.3.2 South America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Recombinant Human Erythropoietin for Injection Market Size by Country
        11.3.1 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Recombinant Human Erythropoietin for Injection Market Drivers
    12.2 Recombinant Human Erythropoietin for Injection Market Restraints
    12.3 Recombinant Human Erythropoietin for Injection Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Recombinant Human Erythropoietin for Injection and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Recombinant Human Erythropoietin for Injection
    13.3 Recombinant Human Erythropoietin for Injection Production Process
    13.4 Recombinant Human Erythropoietin for Injection Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Recombinant Human Erythropoietin for Injection Typical Distributors
    14.3 Recombinant Human Erythropoietin for Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Recombinant Human Erythropoietin for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Recombinant Human Erythropoietin for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Amgen Basic Information, Manufacturing Base and Competitors
    Table 4. Amgen Major Business
    Table 5. Amgen Recombinant Human Erythropoietin for Injection Product and Services
    Table 6. Amgen Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Amgen Recent Developments/Updates
    Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 9. Johnson & Johnson Major Business
    Table 10. Johnson & Johnson Recombinant Human Erythropoietin for Injection Product and Services
    Table 11. Johnson & Johnson Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Johnson & Johnson Recent Developments/Updates
    Table 13. Roche Basic Information, Manufacturing Base and Competitors
    Table 14. Roche Major Business
    Table 15. Roche Recombinant Human Erythropoietin for Injection Product and Services
    Table 16. Roche Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Roche Recent Developments/Updates
    Table 18. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
    Table 19. Kyowa Kirin Major Business
    Table 20. Kyowa Kirin Recombinant Human Erythropoietin for Injection Product and Services
    Table 21. Kyowa Kirin Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Kyowa Kirin Recent Developments/Updates
    Table 23. LG Chem Basic Information, Manufacturing Base and Competitors
    Table 24. LG Chem Major Business
    Table 25. LG Chem Recombinant Human Erythropoietin for Injection Product and Services
    Table 26. LG Chem Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. LG Chem Recent Developments/Updates
    Table 28. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 29. Daewoong Pharmaceutical Major Business
    Table 30. Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
    Table 31. Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Daewoong Pharmaceutical Recent Developments/Updates
    Table 33. Wockhardt Basic Information, Manufacturing Base and Competitors
    Table 34. Wockhardt Major Business
    Table 35. Wockhardt Recombinant Human Erythropoietin for Injection Product and Services
    Table 36. Wockhardt Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Wockhardt Recent Developments/Updates
    Table 38. CJ Healthcare Basic Information, Manufacturing Base and Competitors
    Table 39. CJ Healthcare Major Business
    Table 40. CJ Healthcare Recombinant Human Erythropoietin for Injection Product and Services
    Table 41. CJ Healthcare Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. CJ Healthcare Recent Developments/Updates
    Table 43. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 44. 3SBio Major Business
    Table 45. 3SBio Recombinant Human Erythropoietin for Injection Product and Services
    Table 46. 3SBio Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. 3SBio Recent Developments/Updates
    Table 48. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
    Table 49. Kexing Biopharm Major Business
    Table 50. Kexing Biopharm Recombinant Human Erythropoietin for Injection Product and Services
    Table 51. Kexing Biopharm Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Kexing Biopharm Recent Developments/Updates
    Table 53. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 54. Harbin Pharmaceutical Group Major Business
    Table 55. Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Product and Services
    Table 56. Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Harbin Pharmaceutical Group Recent Developments/Updates
    Table 58. Beijing Four Rings Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 59. Beijing Four Rings Bio-Pharmaceutical Major Business
    Table 60. Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
    Table 61. Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Beijing Four Rings Bio-Pharmaceutical Recent Developments/Updates
    Table 63. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 64. Global Recombinant Human Erythropoietin for Injection Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Recombinant Human Erythropoietin for Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Recombinant Human Erythropoietin for Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Recombinant Human Erythropoietin for Injection Production Site of Key Manufacturer
    Table 68. Recombinant Human Erythropoietin for Injection Market: Company Product Type Footprint
    Table 69. Recombinant Human Erythropoietin for Injection Market: Company Product Application Footprint
    Table 70. Recombinant Human Erythropoietin for Injection New Market Entrants and Barriers to Market Entry
    Table 71. Recombinant Human Erythropoietin for Injection Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 73. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 74. Global Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Recombinant Human Erythropoietin for Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Recombinant Human Erythropoietin for Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 77. Global Recombinant Human Erythropoietin for Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 78. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Global Recombinant Human Erythropoietin for Injection Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Recombinant Human Erythropoietin for Injection Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 83. Global Recombinant Human Erythropoietin for Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 84. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 85. Global Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 86. Global Recombinant Human Erythropoietin for Injection Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Recombinant Human Erythropoietin for Injection Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 89. Global Recombinant Human Erythropoietin for Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 90. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 91. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 92. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 93. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 94. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 95. North America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 96. North America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 99. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 100. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 101. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 102. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 103. Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 104. Europe Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Recombinant Human Erythropoietin for Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 107. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 108. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 109. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 110. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 111. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 112. Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 115. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 116. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 117. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 118. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2023) & (K Units)
    Table 119. South America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2024-2029) & (K Units)
    Table 120. South America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2023) & (K Units)
    Table 123. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2024-2029) & (K Units)
    Table 124. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2023) & (K Units)
    Table 125. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2024-2029) & (K Units)
    Table 126. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2023) & (K Units)
    Table 127. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2024-2029) & (K Units)
    Table 128. Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Recombinant Human Erythropoietin for Injection Raw Material
    Table 131. Key Manufacturers of Recombinant Human Erythropoietin for Injection Raw Materials
    Table 132. Recombinant Human Erythropoietin for Injection Typical Distributors
    Table 133. Recombinant Human Erythropoietin for Injection Typical Customers
List of Figures
    Figure 1. Recombinant Human Erythropoietin for Injection Picture
    Figure 2. Global Recombinant Human Erythropoietin for Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Type in 2022
    Figure 4. Epoetin-alfa Examples
    Figure 5. Epoetin-beta Examples
    Figure 6. Darbepoetin-alfa Examples
    Figure 7. Others Examples
    Figure 8. Global Recombinant Human Erythropoietin for Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Application in 2022
    Figure 10. Anemia Examples
    Figure 11. Kidney Disorders Examples
    Figure 12. Others Examples
    Figure 13. Global Recombinant Human Erythropoietin for Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Recombinant Human Erythropoietin for Injection Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Recombinant Human Erythropoietin for Injection Sales Quantity (2018-2029) & (K Units)
    Figure 16. Global Recombinant Human Erythropoietin for Injection Average Price (2018-2029) & (US$/Unit)
    Figure 17. Global Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Recombinant Human Erythropoietin for Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Recombinant Human Erythropoietin for Injection Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Recombinant Human Erythropoietin for Injection Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 32. Global Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 35. North America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Recombinant Human Erythropoietin for Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Recombinant Human Erythropoietin for Injection Market Drivers
    Figure 76. Recombinant Human Erythropoietin for Injection Market Restraints
    Figure 77. Recombinant Human Erythropoietin for Injection Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Recombinant Human Erythropoietin for Injection in 2022
    Figure 80. Manufacturing Process Analysis of Recombinant Human Erythropoietin for Injection
    Figure 81. Recombinant Human Erythropoietin for Injection Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical

Related Reports

Global Recombinant Human Erythropoietin for Injection Supply, Demand and Key Producers, 2023-2029

Global Recombinant Human Erythropoietin for Injection Supply, Demand and Key Producers, 2023-2029

date 01 Nov 2023

date Pharma & Healthcare

The global Recombinant Human Erythropoietin for Injection market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Global Recombinant Human Erythropoietin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Recombinant Human Erythropoietin for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 19 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin for Injection market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.

Global Recombinant Human Erythropoietin for Injection Supply, Demand and Key Producers, 2024-2030

Global Recombinant Human Erythropoietin for Injection Supply, Demand and Key Producers, 2024-2030

date 06 Mar 2024

date Pharma & Healthcare

The global Recombinant Human Erythropoietin for Injection market size is expected to reach $ 14120 million by 2030, rising at a market growth of 5.9% CAGR during the forecast period (2024-2030).

Product Tags

Recombinant Human Erythropoietin for Injection

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>